Valuation: Amgen Inc.

Market Cap 208B 310,564B 181B 168B 155B 292B 19,816B 297B 1,988B 778B 9,877B 781B 763B 32,705B P/E 2026 *
25.3x
P/E 2027 * 23.2x
Enterprise Value 250B 372,823B 217B 202B 186B 350B 23,789B 357B 2,386B 934B 11,858B 937B 916B 39,261B EV / Sales 2026 *
6.61x
EV / Sales 2027 * 6.33x
Free-Float
99.78%
Yield 2026 *
2.62%
Yield 2027 * 2.77%
1 day-1.63%
1 week-0.45%
Current month-1.63%
1 month+1.79%
3 months+15.14%
6 months+16.48%
Current year+19.56%
1 week 19,840
Extreme 19840
21,270
1 month 18,410
Extreme 18410
21,270
Current year 15,920
Extreme 15920
21,270
1 year 12,320
Extreme 12320
21,270
3 years 4,676.5
Extreme 4676.5
21,270
5 years 1,280.17
Extreme 1280.1667
21,270
10 years 273.67
Extreme 273.6667
21,270
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.63%-0.45% - - 208B
-2.39%-6.24%+47.10%+146.73% 1,024B
-0.76%-3.41%+52.04%+49.73% 618B
-2.33%-5.50%+25.55%+64.08% 443B
+0.68%+0.25%+38.47%+31.95% 349B
-1.66%-1.89%+32.18%+37.17% 297B
-8.96%-9.23%+3.57%+3.64% 264B
-1.37%-5.71%-2.10%-44.43% 209B
+0.72%+1.42%+15.88%+73.30% 162B
+0.08%+2.00%+6.56%-29.19% 143B
Average -1.16%-1.40%+24.36%+37.00% 389.82B
Weighted average by Cap. -0.67%-2.27%+33.84%+65.85%

Financials

2026 *2027 *
Net sales 37.74B 56,377B 32.78B 30.57B 28.1B 52.99B 3,597B 53.92B 361B 141B 1,793B 142B 139B 5,937B 38.66B 57,760B 33.59B 31.32B 28.79B 54.29B 3,685B 55.24B 370B 145B 1,837B 145B 142B 6,083B
Net income 8.21B 12,262B 7.13B 6.65B 6.11B 11.53B 782B 11.73B 78.48B 30.72B 390B 30.82B 30.14B 1,291B 8.83B 13,194B 7.67B 7.15B 6.58B 12.4B 842B 12.62B 84.44B 33.06B 420B 33.16B 32.43B 1,389B
Net Debt 41.67B 62,259B 36.21B 33.75B 31.03B 58.52B 3,973B 59.54B 398B 156B 1,980B 156B 153B 6,556B 36.76B 54,919B 31.94B 29.77B 27.37B 51.62B 3,504B 52.52B 352B 138B 1,747B 138B 135B 5,783B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-08-03 ARS 19,930.00 -1.63% 1,599
26-07-31 ARS 20,260.00 +0.65% 2,057
26-07-30 ARS 20,130.00 -1.37% 1,213
26-07-29 ARS 20,410.00 -2.30% 1,609
26-07-28 ARS 20,890.00 +3.98% 4,118
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
385.16USD
Average target price
357.03USD
Spread / Average Target
-7.30%

Quarterly revenue - Rate of surprise